OZACE

This brand name is authorized in Nigeria.

Active ingredients

The drug OZACE contains one active pharmaceutical ingredient (API):

1	Olanzapine UNII N7U69T4SZR - OLANZAPINE
	Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems.
	Read more about Olanzapine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-6722	Tablet	Ozace-5 Tablets TAB 5 mg 3 x 10's (in Alu-Alu pack)	Tablet Mouth Dissolving Tablet	29/03/2021
A4-6723	Tablet	Ozace-10 Tablets TAB 10 mg 3 x 10's (in Alu-Alu pack)	Film Coated Tablet	29/03/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AH03	Olanzapine	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-6722, A4-6723